Redwood Wealth Management Group’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-46,400
| Closed | -$104K | – | 1013 |
|
|
2024
Q2 | $104K | Buy |
+46,400
| New | +$104K | 0.08% | 187 |
|
|
2024
Q1 | – | Sell |
-42,600
| Closed | -$75.4K | – | 142 |
|
|
2023
Q4 | $75.4K | Buy |
42,600
+4,400
| +12% | +$7.79K | 0.08% | 125 |
|
|
2023
Q3 | $121K | Buy |
38,200
+150
| +0.4% | +$474 | 0.14% | 121 |
|
|
2023
Q2 | $25.2K | Buy |
38,050
+300
| +0.8% | +$198 | 0.03% | 145 |
|
|
2023
Q1 | $30.1K | Buy |
37,750
+2,150
| +6% | +$1.72K | 0.03% | 150 |
|
|
2022
Q4 | $80.5K | Buy |
+35,600
| New | +$80.5K | 0.1% | 127 |
|